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A 35-year-old man was referred to our center because of low grade fever, vomiting, yellow sclera, and tenderness in 
the upper-right quadrant of his abdomen. Laboratory tests showed a white blood cell (WBC) of 7100/μL, a platelet of 
184,000/μL, an erythrocyte sedimentation rate (ESR) of 4 mm/h, an alanine aminotransferase (ALT) of 525 U/L, an as-
partate aminotransferase AST of 142 U/L, a total bilirubin level of 4.23 mg/dL, and a direct bilirubin level of 3.16 mg/
dL. Viral hepatitis markers, immunoglobuline M antibody to cytomegalovirus (anti-CMV IgM), Ebstein-Barr virus (EBV) 
IgM, and immunologic markers of autoimmune hepatitis were negative. The patient was diagnosed with acute hepatitis. 
Alkaline phosphatase was in the normal range throughout the course of the disease. Because of the patient’s occupation 
as a butcher and his history of eating semi-cooked sheep testes, serologic tests of brucellosis were conducted; the tests 
came out positive. We were concerned about the hepatotoxicity of standard regimens; therefore, we started treatment 
with streptomycin and ciprofloxacin regimens. Although liver enzyme had fallen and fever discontinued, the total and 
direct bilirubin concentrations in the patient’s serum both increased in spite of using 2 weeks of the abovementioned 
drug regimen. The elevation of bilirubin could have been due to drug hepatotoxicity. Alternatively, a regimen containing 
ciprofloxacin may have not have been efficient enough and may have had effects on the direct bilirubin concentration. 
Fortunately, within 8 weeks, progressive recovery was noticed. Brucellosis should be considered in the differential di-
agnosis of fever and hepatitis for those who live in endemic areas, especially if his/her job was at high risk for acquir-
ing brucellosis. We recommend taking a careful occupational and behavioral history for patients with acute hepatitis 
syndrome. We assumed that ciprofloxacin was not suitable for brucella hepatitis treatment and also it may cause liver 
damage. The most appropriate treatment is a standard regimen containing doxycycline.
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Introduction
Brucellosis is an endemic zoonosis in the Mediterranean region, including in many 
parts of Iran (1, 2). In the Islamic Republic of Iran, 
brucellosis represents a major health problem (2). 
Incidence of brucellosis in the Qazvin province, in 
the northern part of the country, is considered low 
in comparison with other heavily infected provinces. 
According to data derived from active surveillance, 
the incidence of brucellosis in the Qazvin province 
was 65, 49, 62, 62, and 36 per 100,000 people in the 
years 2002-2006, respectively (3).
Normally brucellosis infection is caused by 
consuming dairy products. However, the bacteria can 
enter the body through contacting infected animals’ 
reproductive tissues and ingestion (4). Human 
brucellosis is a multisystemic disease with a wide 
range of clinical symptoms. Brucellosis can present 
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with various manifestations and any organ in the 
body may be involved. Hepatosplenomegaly, elevated 
liver enzymes, and increased bilirubin levels have 
been reported in brucellosis patients. However acute 
hepatitis is a rare manifestation (5). We report one 
case, a 30-year-old male with acute brucella hepatitis, 
which demands attention because there is rare case in 
the literature about direct hyperbilirubinemia even 
after treatment.
Case Report
In January 2008, a 30-year-old man was brought 
to the physicians’ clinic (Bu-Ali University Hospital, 
Qazvin, Iran) with a history of fever, nausea, 
vomiting, fatigue, and pain in the upper-right 
quadrant of his abdomen. The patient had been 
complaining of these symptoms incessantly for the 
previous 10 days, and his temperature was 37.8°C. A 
clinical examination revealed no pathologic findings 
except yellow sclera and tenderness in the upper-
right quadrant of the abdomen. The laboratory 
results were as follows: leukocyte count: 7.1×103/
µL, platelet count: 184×103/µL, Hemoglobin: 5.6 
g/dL, erythrocyte sedimentation rate: 4 mm/hour, 
serum alanine aminotransferase (ALT): 525 U/L, 
serum aspartate aminotransferase (AST): 142 U/L, 
and total bilirubin level: 4.23 mg/dL (direct: 3.16 
mg/dL). Serum glucose, lipids, urea, creatinine 
levels, and prothrombin time were normal. 
γ-glutamyl transpeptidase (GGT) and serum alkaline 
phosphatase (ALP) were within the normal ranges 
throughout the course of the disease (ALP patient 
value: 195-218 IU/L). Tests of viral hepatitis markers 
(hepatitis B surface antigen [HBsAg], hepatitis B 
core immunoglobuline M antibody [anti-HBc IgM], 
antibody to hepatitis C virus [anti-HCV], hepatitis A 
virus IgM antibody [anti-HAV IgM]) and antibody 
to human immunodeficiency virus (anti-HIV) were 
negative.
In the second stage of the patient’s evaluation, 
it was observed that the other tests (IgM antibody 
to Ebstein-Barr virus [anti-EBV IgM], antibody to 
cytomegalovirus [anti-CMV], and anti-Fasciola) were 
negative, too. In the third step, tests of immunologic 
markers of autoimmune hepatitis (antinuclear 
antibody [ANA], antimitochondrial antibodies 
[AMA], anti-smooth muscle antibody [ASMA], 
perinuclear-staining antineutrophil cytoplasmic 
antibodies [p-ANCA], and antibody to liver-kidney 
microsome type 1 [anti-LKM1]) were conducted and 
came out negative. Because of the patient’s occupation 
as a butcher and his history of eating semi–cooked 
sheep testes, serologic tests of brucellosis were 
conducted. The standard agglutination test (Wright) 
and 2-mercaptoethanol (2ME) titers were 1/320 and 
1/160, respectively. These results indicated that the 
patient had acute hepatitis due to brucellosis.
In treating the patient, we were concerned about 
the hepatotoxicity of standard regimens; hence, we 
started streptomycin (1g/day IM) and ciprofloxacin 
(2×500 mg/day orally) treatments. On the fifth 
day of treatment, the serum ALT level had fallen 
to 116 U/L and fever discontinued, while the total 
and direct bilirubin concentrations in the patient’s 
serum both increased (Table 1). In spite of the 
reported hepatotoxicity of the standard regimen, we 
had to change the treatment to a standard regimen 
(doxycycline and rifampin). Fortunately, within 8 
weeks, we noticed progressive recovery of the patient 
in signs, symptoms, and normalized liver-function 
tests. At the 6-month clinical follow-up, our patient 
had not relapsed and Wright and 2ME titers had 
declined.
Discussion
Brucellosis is a systemic infection in which 
any organ or system of the body may be involved. 
Because the signs and symptoms of brucellosis are 
nonspecific, and isolation of the causative organism 
is difficult, the diagnosis often depends on serologic 
Table 1. Total and direct bilirubin concentrations in patient’s serum
 Test                         Date 2008/2/19 /2/27 /3/1 /3/3 /3/18 /3/26 /4/3 /5/1 2008/6/17
Total bilirubin (mg/dl) 4.23 9.93 13.25 15.16 18.18 22.73 16.27 4.1 0.79
Direct bilirubin (mg/dl) 3.16 7.83 10.57 11.91 14.38 13.18 9.8 1.9 0.26
Indirect bilirubin (mg/dl) 1.07 2.1 2.68 3.25 3.80 9.55 6.47 2.2 0.53
ALT (U/L) 525 207 172 116 96 91 102 53 17
AST (U/L) 142 67 74 39 43 52 59 28 17
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techniques. However the absolute diagnosis of 
brucellosis requires isolation of the bacterium from 
blood or tissue samples (4, 6). In daily practice, the 
diagnosis of brucellosis is established by a positive 
Wright’s agglutination test in a titer of ≥ 1/160 in 
association in an appropriate clinical setting (7). Due 
to several barriers we did not perform a blood culture 
test. First, we did not have access to the BACTEC 
blood culture system for rapid diagnosis. Secondly, 
a routine blood culture is time consuming and the 
results can take 3-4 weeks. Thirdly, there is low 
percentage of positive blood culture for brucellosis 
patients in the reported results in our region.
The brucella infection in our patient was 
demonstrated with positive serology (standard tube 
agglutination test). Agglutination in the presence of 
2-ME was used to distinguish specific IgG (suggestive 
of active disease) from IgM reactivity (7). Our patient 
demonstrated a high titer of 2ME, which was due 
to active disease. Although bovine brucellosis is 
caused mainly by brucella abortus and is still the most 
prevalent, brucella melitensis is the principal cause of 
brucellosis in sheep, goats, and camels (8). Because 
Brucella abortus has not been reported in humans 
in our country (2) and given the patient’s history of 
eating semi-cooked sheep testes; we assumed that the 
etiologic agent in the patient was brucella melitensis.
The liver is frequently involved in both acute and 
chronic brucellosis, and consequently the patient 
experiences a slight increase in transaminase levels 
and mild hepatosplenomegaly, and, more rarely, 
acute hepatitis (1, 4, 9). Increased direct bilirubin 
usually means that the biliary ducts are obstructed. 
ALP levels in our case were not in the range of a 
typical cholestatic case (3 times the upper normal 
limit). Normally an increase in ALP/AST and 
ALP/ALT ratios indicate a cholestatic component. 
Although in the case study these ratios were not 
elevated, our findings suggest that the increased 
direct bilirubin level may not have been due to bile 
duct injury (10). Although liver enzyme had fallen 
and fever discontinued after treatment containing 
ciprofloxacin and streptomycin, the total and direct 
bilirubin concentrations in the patient’s serum 
increased in spite of 2 weeks of the abovementioned 
drug regimens. The elevation of bilirubin could be 
due to drug hepatotoxicity. Alternatively, inadequate 
efficiency of the abovementioned drug regimens may 
have had effects on the direct bilirubin concentration. 
The aminoglycosides (including streptomycin) are 
not hepatotoxic (11), and ciprofloxacin is known 
to have a relatively low occurrence of adverse side 
effects. However, increasing evidence suggests that 
ciprofloxacin may cause severe liver damage (12, 
13). Approximately 1.7% - 1.9% of patients taking 
ciprofloxacin show elevated AST and ALT levels, 
0.8% have an increased ALP concentration, and 0.3% 
have enhanced bilirubin levels. Because Jaundice 
resulting from ciprofloxacin toxicity is transient (14), 
we didn’t perform a liver biopsy.
The proper drug regimen for the treatment of 
acute brucella hepatitis is not definite. Our literature 
search failed to find any report in relation to the 
efficacy of brucella hepatitis treatment regimens. 
Because users of doxycycline tend not to have an 
increased risk of developing hepatotoxicity, it is 
appropriate to begin a standard regimen containing 
doxycycline rather than ciprofloxacin (15, 16). Brucella 
hepatitis can be resolved with antimicrobial therapy, 
and in the absence of other causes (e.g., hepatitis C 
or alcoholism), cirrhosis does not occur despite the 
severity of the inflammation (17). A complete cure of 
brucella hepatitis was seen in our patient.
Conclusions
In our case study, acute hepatitis was the only 
manifestation of brucellosis. Thus, brucellosis should 
be considered in the differential diagnosis of fever and 
hepatitis for those who live in or have visited endemic 
areas, especially if the patient’s job put him/her at high 
risk for acquiring brucellosis (18). We recommended 
a careful occupational and habit history taking of 
our patient, who had acute hepatitis syndrome. 
People at high risk are livestock handlers, slaughter 
industry workers, and veterinarians. Although most 
people become infected by consuming raw milk or 
unpasteurized dairy products, eating semi-cooked testes 
of infected animals may cause infection, too. This case 
study showed that a regimen containing ciprofloxacin 
is not appropriate for brucella hepatitis treatment and a 
regimen containing doxycycline is the preferable option 
for the abovementioned disease course.
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